-
Archives
- June 2013
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- November 2010
- October 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
-
Meta
Daily Archives: November 27, 2007
Éxtasis, un remedio terapéutico contra los desórdenes psiquiátricos
Fuente: Genciencia El éxtasis es una droga ilegal que podría cambiar de chaqueta y ser beneficiosa, así se desprende de los estudios realizados por expertos norteamericanos e israelís con pacientes oncológicos que sufren ansiedad severa o en aquellas personas que … Continue reading
Posted in Drogas ilegales, psiquiatria, Wikipedia
Tagged , , Drogas ilegales, extasis, Genciencia, psiquiatria, Washington Post, Wikipedia
Leave a comment
Effects of Torcetrapib in Patients at High Risk for Coronary Events
ABSTRACT Background Inhibition of cholesteryl ester transfer protein (CETP) has been shown to have a substantial effect on plasma lipoprotein levels. We investigated whether torcetrapib, a potent CETP inhibitor, might reduce major cardiovascular events. The trial was terminated prematurely because … Continue reading
Posted in Efectos Adversos, Medicamentos
Tagged , interaccion medicamentosa, Medicamentos, mortalidad, NEJM, torcetrapib
Leave a comment
PLoS: rodilla flotante, epidemiologia, pronostico y resultados luego de cirugia
Journal of Trauma Managment & Outcomes
Posted in Articulos de interés
Tagged , Cirugia, Epidemiologia, PLoS, pronostico, rodilla, rodilla flotante, Traumatologia
2 Comments
Rimonobant segun la EMEA
Las indicaciones, evaluaciones y riesgos de suicidio ya datan en la EMEA desde Julio de 2007. En España no se encuentra comercializado aun. Los distintos documentos, en inglés, pueden leerse en: http://www.emea.europa.eu/humandocs/Humans/EPAR/acomplia/acomplia.htm
Posted in Efectos Adversos, Medicamentos
Tagged , Acomplia, Efectos Adversos, EMEA, Medicamentos, rimonobant
Leave a comment
GAPURMED/GAPURJovenes